
By Ed Schoonveld, Bill Coyle
Advertisement
Articles by By Ed Schoonveld, Bill Coyle

Advertisement
Latest Updated Articles
US Drug Pricing Debate: Finding some dearly needed real solutionsPublished: February 3rd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
2
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
3
How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins
4
Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access
5
